European Journal of Cancer, 1879-0852

Journal

More filtering options
  1. A novel panel of biomarkers predicts radioresistance in patients with squamous cell carcinoma of the head and neck.

    Åkervall, J., Nandalur, S., Zhang, J., Qian, C-N., Goldstein, N., Gyllerup, P., Ylva Gårdinger, Alm, J., Lorenc, K., Nilsson, K., Resau, J., Wilson, G. & Teh, B., 2014, In : European Journal of Cancer. 50, 3, p. 570-581

    Research output: Contribution to journalArticle

  2. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

    Aleksandrova, K., Pischon, T., Buijsse, B., May, A. M., Peeters, P. H., Bueno-de-Mesquita, H. B., Jenab, M., Fedirko, V., Dahm, C. C., Siersema, P. D., Freisling, H., Ferrari, P., Overvad, K., Tjonneland, A., Trichopoulou, A., Lagiou, P., Naska, A., Pala, V., Mattiello, A., Ohlsson, B. & 5 othersKarin Jirström, Key, T. J., Khaw, K-T., Riboli, E. & Boeing, H., 2013, In : European Journal of Cancer. 49, 16, p. 3526-3536

    Research output: Contribution to journalArticle

  3. No survival difference between robotic and open radical hysterectomy for women with early-stage cervical cancer: results from a nationwide population-based cohort study

    Alfonzo, E., Wallin, E., Linnea Ekdahl, Staf, C., Rådestad, A. F., Reynisson, P., Stålberg, K., Falconer, H., Jan Persson & Dahm-Kähler, P., 2019, In : European Journal of Cancer. 116, p. 169-177 9 p.

    Research output: Contribution to journalArticle

  4. Comment on "The frequency of breast cancer screening: results from the UKCCCR Randomised Trial"

    Ingvar Andersson, 2002, In : European Journal of Cancer. 38, 11, p. 1427-1428

    Research output: Contribution to journalDebate/Note/Editorial

  5. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas

    H Axelson, Henriksson, M., Wang, Y., Magnusson, K. P. & Klein, G., 1995 Nov, In : European Journal of Cancer. 31A, 12, p. 2099-104 6 p.

    Research output: Contribution to journalArticle

  6. Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: An EORTC phase III study (10863)

    Beex, L., Carsten Rose, Mouridsen, H., Jassem, J., Nooij, M., Estape, J., Paridaens, R., Piccart, M., Gorlia, T., Lardenoije, S. & Baila, L., 2006, In : European Journal of Cancer. 42, 18, p. 3178-3185

    Research output: Contribution to journalArticle

  7. Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancer

    Berglund, A., Garmo, H., Robinson, D., Tishelman, C., Holmberg, L., Ola Bratt, Adolfsson, J., Stattin, P. & Lambe, M., 2012, In : European Journal of Cancer. 48, 1, p. 75-84

    Research output: Contribution to journalArticle

  8. Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report

    Bernstein, J. L., Thomas, D. C., Shore, R. E., Robson, M., Boice, J. D. J., Stovall, M., Andersson, M., Bernstein, L., Malone, K. E., Reiner, A. S., Lynch, C. F., Capanu, M., Smith, S. A., Tellhed, L., Teraoka, S. N., Begg, C. B., Olsen, J. H., Mellemkjaer, L., Liang, X., Diep, A. T. & 3 othersÅke Borg, Concannon, P. & Haile, R. W., 2013, In : European Journal of Cancer. 49, 14, p. 2979-2985

    Research output: Contribution to journalArticle

  9. Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe Sweden

    Bill-Axelson, A., Garmo, H., Nyberg, U., Lambe, M., Ola Bratt, Stattin, P., Adolfsson, J. & Steineck, G., 2011, In : European Journal of Cancer. 47, 14, p. 2195-2201

    Research output: Contribution to journalArticle

  10. Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion--a randomised study

    Leif Bjermer, Gruber, A., Sue-Chu, M., Sandström, T., Eksborg, S. & Henriksson, R., 1995, In : European Journal of Cancer. 31, 13-14, p. 2203-2208

    Research output: Contribution to journalArticle

  11. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients

    Bjordal, K., de Graeff, A., Fayers, P. M., Hammerlid, E., van Pottelsberghe, C., Curran, D., Ahlner-Elmqvist, M., Maher, E. J., Meyza, J. W., Bredart, A., Soderholm, A. L., Arraras, J. J., Feine, J. S., Abendstein, H., Morton, R. P., Pignon, T., Huguenin, P., Bottomly, A. & Kaasa, S., 2000, In : European Journal of Cancer. 36, 14, p. 1796-1807

    Research output: Contribution to journalArticle

  12. Long-term risk of renal and urinary tract diseases in childhood cancer survivors: A population-based cohort study

    Bonnesen, T. G., Winther, J. F., Asdahl, P. H., De Fine Licht, S., Gudmundsdottir, T., Anna Sällfors Holmqvist, Madanat-Harjuoja, L. M., Tryggvadottir, L., Wesenberg, F., Birn, H., Olsen, J. H. & Hasle, H., 2016 Sep 1, In : European Journal of Cancer. 64, p. 52-61 10 p.

    Research output: Contribution to journalArticle

  13. Familial risks of breast and prostate cancers: Does the definition of the at risk period matter?

    Brandt, A., Bermejo, J. L., Jan Sundquist & Kari Hemminki, 2010, In : European Journal of Cancer. 46, 4, p. 752-757

    Research output: Contribution to journalArticle

  14. Clinical applications of newer radionuclide therapies

    Brans, B., Lindén, O., Giammarile, F., Jan Tennvall & Punt, C., 2006, In : European Journal of Cancer. 42, 8, p. 994-1003

    Research output: Contribution to journalArticle

  15. Perceptions of genetic research and testing among members of families with an increased risk of malignant melanoma

    Branstrom, R., Kasparian, N. A., Affleck, P., Tibben, A., Chang, Y., Azizi, E., Baron-Epel, O., Bergman, W., Chan, M., Davies, J., Christian Ingvar, Kanetsky, P. A., van Leeuwen, E., Håkan Olsson, Gruis, N. A., Brandberg, Y. & Newton-Bishop, J., 2012, In : European Journal of Cancer. 48, 16, p. 3052-3062

    Research output: Contribution to journalArticle

  16. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer

    O Bratt, Damber, J. E., Emanuelsson, M., U Kristoffersson, Lundgren, R., Håkan Olsson & Grönberg, H., 2000 Jan, In : European Journal of Cancer. 36, 2, p. 235-241

    Research output: Contribution to journalArticle

  17. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study

    O Bratt, U Kristoffersson, Lundgren, R. & Håkan Olsson, 1999 Feb, In : European Journal of Cancer. 35, 2, p. 272-7 6 p.

    Research output: Contribution to journalArticle

  18. Cytostatic drug treatment causes seeding of gene promoter methylation.

    Anders Bredberg & Bodmer, W., 2007, In : European Journal of Cancer. 43, 5, p. 947-954

    Research output: Contribution to journalArticle

  19. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer

    Brennan, D., Sara Ek, Doyle, E., Drew, T., Foley, M., Flannelly, G., O´Conner, D. P., Gallagher, W. M., Kilpinen, S., Kallioniemi, O-P., Jirström, K., O'Herlihy, C. & Carl Borrebaeck, 2009, In : European Journal of Cancer. 45, 8, p. 1510-1517

    Research output: Contribution to journalArticle

  20. The PanCareSurFup consortium: research and guidelines to improve lives for survivors of childhood cancer

    Byrne, J., Alessi, D., Allodji, R. S., Bagnasco, F., Bárdi, E., Bautz, A., Bright, C. J., Brown, M., Diallo, I., Feijen, E. A. M. L., Fidler, M. M., Frey, E., Garwicz, S., Grabow, D., Gudmundsdottir, T., Hagberg, O., Harila-Saari, A., Hau, E. M., Haupt, R., Hawkins, M. M. & 30 othersJakab, Z., Jankovic, M., Kaatsch, P., Kaiser, M., Kremer, L. C. M., Kuehni, C. E., Kuonen, R., Ladenstein, R., Lähteenmäki, P. M., Levitt, G., Helena Linge, LLanas, D., Michel, G., Morsellino, V., Mulder, R. L., Reulen, R. C., Ronckers, C. M., Sacerdote, C., Skinner, R., Steliarova-Foucher, E., van der Pal, H. J., de Vathaire, F., Vũ Bezin, G., Wesenberg, F., Thomas Wiebe, Winter, D. L., Falck Winther, J., Elise Witthoff, Zadravec Zaletel, L. & Lars Hjorth, 2018, In : European Journal of Cancer. 103, p. 238-248 11 p.

    Research output: Contribution to journalArticle

  21. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.

    Carlsson, A., Christer Wingren, Ingvarsson, J., Ellmark, P., Bo Baldetorp, Mårten Fernö, Håkan Olsson & Carl Borrebaeck, 2008, In : European Journal of Cancer. 44, 3, p. 472-480

    Research output: Contribution to journalArticle

  22. Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.

    Cashin, P. H., Mahteme, H., Spång, N., Ingvar Syk, Frödin, J. E., Torkzad, M., Glimelius, B. & Graf, W., 2016, In : European Journal of Cancer. 53, p. 155-162

    Research output: Contribution to journalArticle

  23. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer

    Castro, F. A., Asta Försti, Buch, S., Kalthoff, H., Krauss, C., Bauer, M., Egberts, J., Schniewind, B., Broering, D. C., Schreiber, S., Schmitt, M., Hampe, J., Kari Hemminki & Schafmayer, C., 2011, In : European Journal of Cancer. 47, 8, p. 1203-1210

    Research output: Contribution to journalArticle

  24. Risk of subsequent cancers in renal cell carcinoma survivors with a family history.

    Chen, T., Mahdi Fallah, Kristina Sundquist, Liu, H. & Kari Hemminki, 2014, In : European Journal of Cancer. 50, 12, p. 2108-2118

    Research output: Contribution to journalArticle

  25. Reduced mortality for women with mammography-detected breast cancer in east Denmark and south Sweden

    Christensen, L. H., Engholm, G., Cortes, R., Ceberg, J., Tange, U., Andersson, M., Bladström, A., Mouridsen, H. T., Möller, T. & Storm, H., 2006, In : European Journal of Cancer. 42, 16, p. 2773-2780

    Research output: Contribution to journalArticle

  26. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? - A population-based study

    Christensen, LH., Engholm, G., Ceberg, J., Hein, S., Perfekt, R., Tange, UB., Andersson, M., Mouridsen, HT., Möller, T. & Storm, HH., 2004, In : European Journal of Cancer. 40, 8, p. 1233-1243

    Research output: Contribution to journalArticle

  27. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition

    Chuang, S-C., Stolzenberg-Solomon, R., Ueland, P. M., Vollset, S. E., Midttun, O., Olsen, A., Tjonneland, A., Overvad, K., Boutron-Ruault, M-C., Morois, S., Clavel-Chapelon, F., Teucher, B., Kaaks, R., Weikert, C., Boeing, H., Trichopoulou, A., Benetou, V., Naska, A., Jenab, M., Slimani, N. & 26 othersRomieu, I., Michaud, D. S., Palli, D., Sieri, S., Panico, S., Sacerdote, C., Tumino, R., Skeie, G., Duell, E. J., Rodriguez, L., Molina-Montes, E., Maria Huerta, J., Larranaga, N., Barricarte Gurrea, A., Dorthe Johansen, Jonas Manjer, Ye, W., Sund, M., Peeters, P. H. M., Jeurnink, S., Wareham, N., Khaw, K-T., Crowe, F., Riboli, E., Bueno-de-Mesquita, B. & Vineis, P., 2011, In : European Journal of Cancer. 47, 12, p. 1808-1816

    Research output: Contribution to journalArticle

  28. An internadional field study of the reliability and validity of a disease-specfic questionnanire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma

    Cocks, K., Cohen, D., Wisloff, F., Sezerc, O., Lee, S., Hippe, E., Gimsing, P., Ingemar Turesson, Hajek, R., Smith, A., Graham, L., Phillips, A., Stead, M., Velikova, G. & Brown, J., 2007, In : European Journal of Cancer. 43, 11, p. 1670-1678

    Research output: Contribution to journalArticle

  29. Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions

    Cserni, G., Amendoeira, I., Bianchi, S., Chmielik, E., DeGaetano, J., Faverly, D., Figueiredo, P., Foschini, M. P., Grabau, D., Jacquemier, J., Kaya, H., Kulka, J., Lacerda, M., Liepniece-Karele, I., Martinez Penuela, J., Quinn, C., Regitnig, P., Reiner-Concin, A., Sapino, A., van Diest, P. J. & 6 othersVarga, Z., Vezzosi, V., Wesseling, J., Zolota, V., Zozaya, E. & Wells, C. A., 2011, In : European Journal of Cancer. 47, 6, p. 887-894

    Research output: Contribution to journalArticle

  30. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

    Dimopoulos, M. A., Grosicki, S., Jędrzejczak, W. W., Nahi, H., Gruber, A., Markus Hansson, Gupta, N., Byrne, C., Labotka, R., Teng, Z., Yang, H., Grzasko, N. & Kumar, S., 2019, In : European Journal of Cancer. 106, p. 89-98 10 p.

    Research output: Contribution to journalArticle

  31. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

    Elomaa, I., Blomqvist, C. P., Saeter, G., Akerman, M., Stenwig, E., Thomas Wiebe, Bjork, O. & Thor Alvegård, 2000, In : European Journal of Cancer. 36, 7, p. 875-880

    Research output: Contribution to journalArticle

  32. Identification of low-risk tumours in histological high-grade soft tissue sarcomas

    Jacob Engellau, Samuelsson, V., Anderson, H., Bjerkehagen, B., Rissler, P., Sundby-Hall, K. & Anders Rydholm, 2007, In : European Journal of Cancer. 43, 13, p. 1927-1934

    Research output: Contribution to journalArticle

  33. Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer

    Ericson, K., Halvarsson, B., Nagel, J., Rambech, E., M Planck, Piotrowska, Z., Olsson, H. & M Nilbert, 2003 Jan, In : European Journal of Cancer. 39, 2, p. 240-8 9 p.

    Research output: Contribution to journalArticle

  34. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: A nationwide population-based study in Sweden

    Eriksson, H., Lyth, J., Mansson-Brahme, E., Frohm-Nilsson, M., Christian Ingvar, Lindholm, C., Naredi, P., Stierner, U., Wagenius, G., Carstensen, J. & Hansson, J., 2013, In : European Journal of Cancer. 49, 12, p. 2705-2716

    Research output: Contribution to journalArticle

  35. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

    Mikael Eriksson, Reichardt, P., Sundby Hall, K., Schütte, J., Cameron, S., Hohenberger, P., Bauer, S., Leinonen, M., Reichardt, A., Rejmyr Davis, M., Thor Alvegård & Joensuu, H., 2016, In : European Journal of Cancer. 59, p. 128-133 6 p.

    Research output: Contribution to journalArticle

  36. Familial melanoma by histology and age: Joint data from five Nordic countries.

    Mahdi Fallah, Pukkala, E., Kristina Sundquist, Tretli, S., Olsen, J. H., Tryggvadottir, L. & Kari Hemminki, 2014, In : European Journal of Cancer. 50, 6, p. 1176-1183

    Research output: Contribution to journalArticle

  37. Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients

    Fernebro, E., Madsen, R. R., Mårten Fernö, Brunner, N., Pär-Ola Bendahl, Christensen, I. J., Johnson, A. & Mef Nilbert, 2001, In : European Journal of Cancer. 37, 4, p. 486-491

    Research output: Contribution to journalArticle

  38. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group

    Mårten Fernö, Bo Baldetorp, Åke Borg, Brouillet, J. P., Håkan Olsson, Rochefort, H., Sellberg, G., Sigurdsson, H. & Dick Killander, 1994, In : European Journal of Cancer. 30a, 14, p. 2042-2048

    Research output: Contribution to journalArticle

  39. Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

    Fredstorp-Lidebring, M., Pär-Ola Bendahl, Brunner, N., Casslén, B., Thomas Högberg, Långström-Einarsson, E., Willén, R. & Mårten Fernö, 2001, In : European Journal of Cancer. 37, 18, p. 2339-2348

    Research output: Contribution to journalArticle

  40. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

    Fritz, H., David Lindgren, Ljungberg, B., Håkan Axelson & Björn Dahlbäck, 2014, In : European Journal of Cancer. 50, 10, p. 1758-1765

    Research output: Contribution to journalArticle

  41. Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)

    E. Gezelius, P. O. Bendahl, K. Gonçalves de Oliveira, Ek, L., Bergman, B., Sundberg, J., Strandberg, K., Krämer, R. & M. Belting, 2019 Sep, In : European Journal of Cancer. 118, p. 82-90 9 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 Next